Monitor for insider transactions and upcoming commentary on CEO search progress; the Q4 2026 data readout for HLP003 remains a key near-term catalyst.
Price Chart
Executive Summary
Cybin Inc. (HELP) announced the immediate departure of CEO Michael Cola and the appointment of co-founder Eric So as interim CEO while the board conducts a search for a permanent successor. The company reaffirmed its focus on advancing its clinical pipeline, including the upcoming Q4 2026 topline data readout from the Phase 3 APPROACH trial of HLP003 for major depressive disorder.
Key Facts
- CEO Michael Cola stepped down effective immediately at the request of the board
- Co-founder and Executive Chairman Eric So has resumed role as interim CEO
- Board has initiated a search for a permanent CEO
- Company reiterated focus on Q4 2026 topline data readout from the APPROACH trial of HLP003
- HLP003 has Breakthrough Therapy Designation from the FDA for adjunctive treatment of major depressive disorder
Financial Impact
No immediate financial impact disclosed; leadership transition may affect execution risk
Risk Factors
- Leadership transition introduces execution risk during a critical phase of clinical development
- Delays or negative results from the APPROACH trial could materially impact valuation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001833141-26-000024 |
| Document: cybininc-form6xk04x20x2026.htm | 0001833141-26-000024 |
| Document: 0001833141-26-000024-index-headers.html | 0001833141-26-000024 |
| Document: 0001833141-26-000024-index.html | 0001833141-26-000024 |
| Document: 0001833141-26-000024.txt | 0001833141-26-000024 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 3 | $10.11 | awaiting T+20 | — | $10.36 (+2.47%) |
Oct 26, 2026 today | 3 | $10.86 | awaiting T+20 | — | $10.36 (−4.56%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 23, 2026 3d ago | 3 | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 21, 2026 5d ago | 6-K | $10.50 | awaiting T+20 | — | $10.36 (−1.33%) |
Oct 15, 2026 11d ago | 6-K | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 15, 2026 11d ago | Press Release | $11.05 | awaiting T+20 | — | $10.36 (−6.24%) |
Oct 8, 2026 18d ago | 6-K | $10.72 | awaiting T+20 | — | $10.36 (−3.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers